Browse Category

NYSE:MPW News 27 December 2025 - 4 January 2026

MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

NEW YORK, January 3, 2026, 17:44 ET — Market closed Medical Properties Trust, Inc. (NYSE: MPW) shares climbed 1.6% on Friday to close at $5.08. U.S. markets are closed on Saturday. Nasdaq The move matters because MPW is a high-yield real estate investment trust, or REIT — a structure that typically returns a large share of taxable income to investors…
Medical Properties Trust (MPW) Stock News: Wall Street Zen Downgrade, Analyst Targets, and What Investors Should Watch Before Monday’s Open

Medical Properties Trust (MPW) Stock News: Wall Street Zen Downgrade, Analyst Targets, and What Investors Should Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 5:10 p.m. ET — Market closed Medical Properties Trust, Inc. (NYSE: MPW) heads into the final trading days of 2025 with its stock pinned near the mid-$5 range after a quiet, holiday-thinned week for U.S. equities — and after a fresh weekend analyst downgrade added a new headline for investors to weigh. MPW finished Friday’s…
Medical Properties Trust (MPW) Stock: Dividend Hike, Buyback Plan, and a 2026 Debt Wall in Focus as Wall Street Heads Into Year‑End

Medical Properties Trust (MPW) Stock: Dividend Hike, Buyback Plan, and a 2026 Debt Wall in Focus as Wall Street Heads Into Year‑End

NEW YORK — Saturday, December 27, 2025 (12:51 a.m. ET) — With U.S. markets in thin, post‑holiday trading and investors eyeing the traditional “Santa Claus rally” window, Medical Properties Trust Inc. (NYSE: MPW) is heading into the final sessions of 2025 with a familiar mix of income appeal and balance‑sheet anxiety. Reuters MPW, a hospital-focused REIT, last traded around $5.08…

Stock Market Today

  • Sherwin-Williams Q4 2025 Revenue Beats Expectations, Adjusted EPS Surpasses Estimates
    January 29, 2026, 9:55 AM EST. Sherwin-Williams (NYSE:SHW) reported Q4 CY2025 revenue of $5.60 billion, exceeding Wall Street estimates by 0.8%. Adjusted earnings per share (EPS) rose 3.1% above consensus to $2.23. Adjusted EBITDA hit $993.1 million, beating forecasts by 7.1% with a 17.7% margin. Operating margin held steady at 13.9% year-over-year. CEO Heidi G. Petz highlighted core business strength and contributions from the Suvinil acquisition. Despite short-term beats, Sherwin-Williams's five-year compound annual sales growth remains modest at 5.1%, and recent two-year growth slowed to 1.1%. Analysts forecast 4.5% revenue growth for 2026 but adjusted EPS guidance of $11.70 falls short by 5.5%. The paint industry's leader shows steady but cautious outlook amid evolving market demands.
Go toTop